| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Paul La Rosée | Q50761099 |
| Kenneth L McClain | Q57017341 | ||
| Milen Minkov | Q63466836 | ||
| Cristhiam M Rojas-Hernandez | Q86077045 | ||
| Naval Daver | Q88327648 | ||
| Zaher K Otrock | Q95940767 | ||
| Boris Blechacz | Q124061109 | ||
| P2093 | author name string | Hagop M Kantarjian | |
| Carl E Allen | |||
| Sa Wang | |||
| Michael B Jordan | |||
| Sameer A Parikh | |||
| P2860 | cites work | Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis | Q27023603 |
| How I treat hemophagocytic lymphohistiocytosis in the adult patient | Q28258655 | ||
| Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis | Q28308141 | ||
| Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review | Q33357155 | ||
| Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature | Q33358715 | ||
| Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey. | Q33386558 | ||
| Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults | Q33395071 | ||
| Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis | Q33429617 | ||
| Current concepts in the diagnosis and management of cytokine release syndrome | Q33886879 | ||
| CD163: a specific marker of macrophages in paraffin-embedded tissue samples | Q33982414 | ||
| Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood | Q34214820 | ||
| HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. | Q34561113 | ||
| A web-based delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients | Q35141815 | ||
| How I treat hemophagocytic lymphohistiocytosis | Q35483540 | ||
| Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol | Q35525318 | ||
| Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. | Q35585941 | ||
| Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis | Q36253959 | ||
| Infections associated with haemophagocytic syndrome. | Q37018227 | ||
| Hemophagocytic lymphohistiocytosis: when the immune system runs amok | Q37587071 | ||
| Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. | Q37618900 | ||
| Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race | Q37642686 | ||
| Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature | Q37784476 | ||
| Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis | Q38064531 | ||
| Adult haemophagocytic syndrome | Q38167486 | ||
| Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability | Q38171744 | ||
| Hereditary and acquired hemophagocytic lymphohistiocytosis | Q38259614 | ||
| Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes | Q39722802 | ||
| Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis | Q40179549 | ||
| Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. | Q40198507 | ||
| Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. | Q40206962 | ||
| Hemophagocytic lymphohistiocytosis: critical reappraisal of a potentially under-recognized condition | Q40231531 | ||
| Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy. | Q40247636 | ||
| Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis | Q40360876 | ||
| Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome | Q40429306 | ||
| An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder | Q40536555 | ||
| Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation | Q40574611 | ||
| Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS. | Q40595721 | ||
| Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. | Q40714850 | ||
| Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis | Q40749715 | ||
| IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis | Q40766091 | ||
| Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies | Q40972864 | ||
| Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents | Q41259978 | ||
| Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis | Q41751139 | ||
| Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis | Q41751145 | ||
| Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. | Q42260141 | ||
| Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis | Q43013855 | ||
| Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases | Q44529451 | ||
| Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center | Q44930971 | ||
| First description of single-pass albumin dialysis combined with cytokine adsorption in fulminant liver failure and hemophagocytic syndrome resulting from generalized herpes simplex virus 1 infection | Q45344879 | ||
| Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis | Q45374288 | ||
| Clinicopathological findings of virus-associated hemophagocytic syndrome in bone marrow: association with Epstein-Barr virus and apoptosis | Q45747496 | ||
| Treatment of hemophagocytic lymphohistiocytosis in adults. | Q50761068 | ||
| Hemophagocytic syndrome associated with hematological neoplasias. | Q50863201 | ||
| Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. | Q51104436 | ||
| The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. | Q53039315 | ||
| Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. | Q53576234 | ||
| Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. | Q53916622 | ||
| CD163 | Q56593680 | ||
| Immunotherapy of Familial Hemophagocytic Lymphohistiocytosis With Antithymocyte Globulins: A Single-Center Retrospective Report of 38 Patients | Q57014817 | ||
| Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society | Q68192027 | ||
| Familial hemophagocytic lymphohistiocytosis | Q70290216 | ||
| Familial hemophagocytic lymphohistiocytosis and viral infections | Q70462725 | ||
| Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A | Q70482969 | ||
| Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults | Q72772336 | ||
| HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society | Q73274251 | ||
| A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma | Q77229527 | ||
| Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia | Q80565862 | ||
| Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome | Q83834089 | ||
| High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults | Q84470366 | ||
| Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease | Q87635679 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemophagocytic lymphohistiocytosis | Q1642170 |
| P304 | page(s) | 3229-3240 | |
| P577 | publication date | 2017-06-16 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults | |
| P478 | volume | 123 |
| Q57491213 | Acute liver failure secondary to severe systemic disease from fatal hemophagocytic lymphohistiocytosis: Case report and systematic literature review |
| Q100962742 | Diagnostic strategy for trigger identification in severe reactive hemophagocytic lymphohistiocytosis: a diagnostic accuracy study |
| Q98386256 | Haemophagocytic lymphohistiocytosis in adult critical care |
| Q92002051 | Hemophagocytic Lymphohistiocytosis in Adults: Associated Diagnoses and Outcomes, a Ten-Year Experience at a Single Institution |
| Q89794829 | Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry |
| Q55252709 | Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report. |
| Q92320784 | Hepatic sinusoidal hemophagocytosis with and without hemophagocytic lymphohistiocytosis |
| Q97521459 | Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications |
| Q92963506 | MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers |
| Q92736295 | Macrophage Activation Syndrome Secondary to Underlying Sarcoidosis |
| Q47240802 | Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma |
| Q98172049 | SARS-CoV-2 and cancer: Are they really partners in crime? |
| Q99412074 | Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia |
| Q90470620 | The Conundrum of Septic Shock Imitators in Patients with Hematologic Cancers: Case Presentation and Possible Differential Diagnoses |
| Q89550266 | [Clinical significance of secondary hemophagocytic lymphohistiocytosis with pleural effusion] |
Search more.